ANGPTL3 inhibition for hypercholesterolaemia
- PMID: 33235372
- DOI: 10.1038/s41569-020-00483-3
ANGPTL3 inhibition for hypercholesterolaemia
Comment on
-
Evinacumab in Patients with Refractory Hypercholesterolemia.N Engl J Med. 2020 Dec 10;383(24):2307-2319. doi: 10.1056/NEJMoa2031049. Epub 2020 Nov 15. N Engl J Med. 2020. PMID: 33196153 Clinical Trial.
References
Original article
-
- Rosenson, R. S. et al. Evinacumab in patients with refractory hypercholesterolemia. N. Engl. J. Med. https://doi.org/10.1056/NEJMoa2031049 (2020) - DOI - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous